WNK2 and neoplasm: MAP2K1 encodes a mitogen-activated protein kinase (MAPK), which exhibits activating mutations implicated in several cancers including ovarian, melanoma, and lung cancers, and its inhibition has demonstrated efficacy in restraining tumor growth in these contexts [30].